National Peroxide Financials

BSE: 544205

₹619.55

₹-13.55 (-2.14%)

As on 08-Sep-2026IST

Market cap

₹355 Cr

Revenue (TTM)

₹319 Cr

P/E Ratio

19.7

P/B Ratio

Div. Yield

1.1 %

Income Statement (₹ Cr)	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21
Operating Revenue	319.12	286.87	332.99	377.09	--	--
Total Income	325.20	291.36	338.82	384.73	--	--
Total Expenditure	280.52	271.66	296.06	317.36	--	--
EBITDA	38.61	15.21	36.93	59.73	--	--
Depreciation	20.93	20.11	19.26	19.80	--	--
EBIT	17.67	-4.90	17.67	39.93	--	--
Interest	1.26	1.67	1.98	7.02	--	--
Other Income	6.07	4.49	5.83	7.64	--	--
Exceptional Items	-0.58	--	--	12.95	--	--
Profit before Tax	21.91	-2.08	21.51	53.50	--	--
Provision for Tax	3.85	0.17	4.72	14.00	--	--
Profit after Tax	18.06	-2.25	16.79	39.50	--	--

Liabilities (₹ Cr)	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21
Shareholder's Funds	356.81	349.27	358.96	351.99	--	--
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	51.84	67.23	70.32	61.03	--	--
Current Liabilities	50.06	36.62	40.89	48.25	--	--
Total Liabilities	458.70	453.11	470.17	461.27	--	--

Assets (₹ Cr)	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21
Non-Current Assets	298.32	332.29	350.13	339.93	--	--
Current Assets	138.80	120.81	120.03	121.26	--	--
Total Assets	458.70	453.11	470.17	461.27	--	--
Total Debt*	--	7.01	10.46	13.92	--	--
Net Current Assets	88.75	84.20	79.15	73.01	--	--
Contingent Liabilities	--	--	--	--	--	--

Cashflow (₹ Cr)	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21
Cash From Operating Activities	--	18.67	36.40	67.11	--	--
Cash Flow from Investing Activities	--	-1.73	-17.51	24.79	--	--
Cash from Financing Activities	--	-12.54	-16.72	-85.96	--	--
Net Cash Inflow / Outflow	--	4.40	2.18	5.93	--	--

Financials Ratios	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21
Adjusted EPS (₹)	32.46	-3.91	29.22	--	--	--
Cash EPS (₹)	31.42	31.08	62.73	--	--	--
Adjusted Book Value (₹)	632.35	607.73	624.61	--	--	--
Dividend per Share (₹)	1.13	--	12.50	--	--	--
Cash Flow per Share (₹)	--	32.48	63.34	--	--	--
Free Cash Flow per Share (₹)	--	31.10	44.85	--	--	--

Profitability Ratios	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21
ROCE (%)	--	-0.11	6.39	16.54	--	--
ROE (%)	5.28	-0.63	4.76	11.41	--	--
ROA (%)	4.01	-0.49	3.61	8.56	--	--
EBIT Margin (%)	5.54	-1.71	5.31	10.59	--	--
Net Margin (%)	5.55	-0.77	4.96	10.27	--	--
Cash Profit Margin (%)	--	5.68	9.98	14.69	--	--

Growth Ratios	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21
Revenue Growth (%)	14.16	-13.85	-11.70	--	--	--
EBIT Growth (%)	267.25	-127.73	-55.76	--	--	--
Net Profit Growth (%)	389.69	-113.38	-57.49	--	--	--
EPS Growth (%)	380.39	-113.38	--	--	--	--
Book Value Growth (%)	--	-2.70	3.67	--	--	--

Valuation Ratios	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21
Price / Earnings	19.67	--	--	--	--	--
Price / Book Value	0.98	0.95	--	--	--	--
Dividend Yield (%)	1.13	--	--	--	--	--
EV/EBITDA	7.41	15.99	-0.02	0.10	--	--
Close Price (₹)	574.05	577.00	--	--	--	--
High Price (₹)	770.00	1,418.05	--	--	--	--
Low Price (₹)	350.00	552.20	--	--	--	--
Market Cap (₹ Cr)	355.25	331.60	--	--	--	--

Solvency Ratios	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21
Debt to Equity	--	0.02	0.03	0.04	--	--
Short term debt to equity ratio	--	--	--	0.00	--	--
Current Ratio	2.77	3.30	2.94	2.51	--	--
Quick Ratio	2.01	2.41	2.11	1.76	--	--
Interest Coverage	18.46	-0.25	11.86	8.62	--	--

Operating Efficiency Ratios	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21
Debtors to sales (%)	8.02	7.95	8.15	6.44	--	--
Asset Turnover	0.71	0.68	0.78	0.88	--	--
Receivable days	--	28.99	25.99	21.94	--	--
Inventory Days	--	38.50	35.38	32.69	--	--
Payable days	--	51.87	51.54	46.48	--	--
Cash Conversion Cycle	--	15.62	9.83	8.16	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Income Statement (₹ Cr)